Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide.
Synthetic oligodeoxynucleotides complementary to the break-point junction of bcr-abl transcripts selectively inhibit the proliferation of Philadelphia-positive leukemic cells, but residual leukemic cells persist in antisense oligodeoxynucleotides-treated cultures. Cyclophosphamide derivatives such a...
Guardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Clinical Investigation
1993
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC293565/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8325984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116549 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
